Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions by Yongming Jin, Fei Chen, Gang Xu, Chaogang Wei, Congsong Dong

Subjects: Get full text

3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study by Jie Bao, Litao Zhao, Xiaomeng Qiao, Zhenkai Li, Yanting Ji, Yueting Su, Libiao Ji, Junkang Shen, Jiangang Liu, Jie Tian, Ximing Wang, Hailin Shen, Chunhong Hu

Subjects: Get full text

Development of novel nomograms for predicting prostate cancer in biopsy-naive patients with PSA < 10 ng/ml and PI-RADS ≤ 3 lesions by Jia-gui Chai, Yu-hang Li, Chang-xing Ke

Subjects: Get full text

Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions by Mustafa Koplay, Ali Furkan Batur, Serdar Göktaş, Mehmet Kaynar, Halil Özer, Ahmet Baytok, Ömer Faruk Topaloğlu

Subjects: “…pi-rads v2.1…”
Get full text

Ultra-fast biparametric MRI in prostate cancer assessment: Diagnostic performance and image quality compared to conventional multiparametric MRI by Antonia M. Pausch, Vivien Filleböck, Clara Elsner, Niels J. Rupp, Daniel Eberli, Andreas M. Hötker

Subjects: Get full text

Malacoplaquia prostática diagnosticada como lesión PI-RADS 5 asociada a absceso prostático en paciente inmunocompetente by Luis D. Nuño-Uscanga, José B. Cisneros-Madrid, Alejandro Madero-Arteaga, José P. Lomelín-Ramos, Yeni Fernández de Lara-Barrera, Danny R. Soria-Céspedes, Brandon Martínez-Torres, Juan P. López-Calderón

Subjects: “…Absceso prostático. Michaelis-Gutmann. PI-RADS 5.…”
Get full text